Bergstrom Donald A 4

What Happened

Donald A. Bergstrom, President of Research & Development at Relay Therapeutics (RLAY), disposed of 1,490 shares on 2026-04-28 at $14.79 per share for proceeds of $22,037. The filing reports this was a sale (code S) done to satisfy income tax withholding obligations related to recent RSU vesting, not an independent open‑market trade intended as an investment signal.

Key Details

• Transaction date and price: 2026-04-28, 1,490 shares sold at $14.79 each (total ≈ $22,037).
• Reason: Sale to cover tax withholding on vesting of 5,012 RSUs (vested 2026-04-27); sale was not at the reporting person's discretion and followed issuer policy (footnote F1).
• Holdings note: Form indicates "Includes 15,037 shares underlying RSUs" (footnote F2). The Form 4 does not state a different total post‑sale share count.
• Filing: Report filed 2026-04-30 for the 2026-04-28 transaction — appears to be a timely Form 4 filing.

Context

This was a routine, tax‑withholding sale following RSU vesting rather than a discretionary sell for liquidity or market-timing. Such transactions are common when restricted stock units vest; they do not necessarily indicate management sentiment about the company. Purchases generally carry more informational weight for investors than routine withholding sales.